Clinical Trial Update: Study of FOLFIRI Plus Bevacizumab in Colorectal Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating FOLFIRI plus bevacizumab in colorectal cancer; the study is completed and results were posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Bevacizumab (bevacizumab)
• Irinotecan (Irinotecan)
• Leucovorin (folinic acid)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2011-10-21